GPT and metabolic dysfunction-associated steatotic liver disease: In HFD-induced male NAFLD rats, SCPs reduced the serum level of AST, ALT, TG, TC, and LDL-C, and increased the level of HDL-C, indicating that SCPs alleviate the occurrence of NAFLD by regulating the expression of UDP-glucose pyrophosphorylase (UGP2), UDP-glucose 6-dehydrogenase (UGDH), acetyl coenzyme carboxylase (ACC), and fatty acid synthase (FAS) in the liver of NAFLD rats [144].